Navigation Links
DYNALINK® 0.018 Biliary Self-Expanding Stent System

ProductsDYNALINK® 0.018 Biliary Self-Expanding Stent System
Company Guidant Corporation
Item DYNALINK® 0.018 Biliary Self-Expanding Stent System
Features 
  • The DYNALINK™ .018 System is 6F sheath / 8F guiding catheter compatible in all sizes
  • The proximal shaft of the DYNALINK™ .018 System is 4.5F, allowing for contrast injection through a 6F sheath
  • The DYNALINK .018 System offers very minimal shortening 1.42% on 8.0 x 38 mm stent
  • The DYNALINK .018 System is very accurate, which is a result of the fixed handle design and the minimal stent shortening
  • On average, testing showed it was 0.53 mm from a deployment target
Description The DYNALINK .018 Biliary Self-Expanding Stent System combines low-profile, high radial force, and excellent deliverability in one system. This .018" guide wire compatible stent system provides 6F sheath / 8F guiding catheter compatibility in all diameters (5.0 - 10.0 mm). Now, with longer stents available, the DYNALINK .018 system is offered in five stent lengths (28, 38, 56, 80 and 100 mm) and two catheter lengths (80 and 120 cm).

The DYNALINK .018 system's unique handle and minimal shortening enable unparalleled placement accuracy, and its self-expanding stent is made of crush-resistant nitinol, offering excellent flexibility, conformability, and radial strength.

Info Guidant Corporation
Customer Service: (317) 971-2000
Web site: http://www.guidant.com/

Related medicine products :

1. Express Biliary SD Stent System 150 cm
2. Express Biliary SD Stent System 90 cm
3. Sentinol™ Self-Expanding Nitinol Biliary Stent System
4. Spencer Modified Biliary Wire Guides
5. Zilver 518 Biliary Stent
6. ABSOLUTE™ 0.035 Biliary Self-Expanding Stent System
7. OMNILINK® 0.035 Biliary Stent System
8. RX HERCULINK® PLUS Biliary Stent System
9. WaveMax Biliary Stent
10. PRECISE® Nitinol Self-Expanding Stent
11. PROTG® GPS™ Self-Expanding Nitinol Stent
Charmant's Pure Titanium Collection is the world's most extensive collection of titanium frames, consisting of 100% pure titanium and beta-titanium frames with ultra-lightweight strength, hypoallerge
The license agreement between Brook Brothers and Luxottica Group dates back to 1993. Characterized by lightweight materials and a slender line, the Brooks Brothers collections reflect the unique feat
The new Chanel optical collection, inspired by the codes of elegance dear to Mademoiselle's heart, from the interlinked double C to the quilted effect. Combining the purity of black with the sparkle
...sh restatement of everything thats creative and so...he creations include eighteen ladies models and fo...The style icons of the Florentine brand reassert t...s, striking details and prestige materials.,The Wo...
Medicine Products:
(Date:12/3/2008)... 2008 , , LOVELAND, Ohio, Dec. 3 /PRNewswi...I), a non-profit 501(c)(3) organization, is please... its new Methods Evaluation ProcessTM (MEPTM) Accr...l host a complimentary Webinar to provide an overv...In order to make transparent attributions between ...
(Date:12/3/2008)...eat, a MED3OOO company that,delivers EHR technolo...,clinics, recently entered into a 14-year Applicat...althCare Alliance to provide electronic medical re..., The WVVA Healthcare Alliance is made up of... the Alleghany Highlands of Virginia and the Green...
(Date:12/3/2008)..., researchers say , , WEDNESDAY, Dec. 3 ...chiatric conditions have faulty circuitry in the p... study suggests. , For the study, researchers p...ients, those with major depression and those with ... group. , The researchers then used functional...
(Date:12/3/2008)...any dentists and dental office,staff have realize...ever, very,few dental professionals have taken ad...ectronic transactions may increase office efficien... benefit information while the patient is still,i...y take 10 to 14 business days to process. By,usin...
Breaking Medicine News(10 mins):Health News:Population Health Impact Institute Invites Organizations To Serve as Test Sites for Methods Evaluation Process(TM) (MEP(TM)) Accreditation Program: 2Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 2Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 3Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 4Health News:Memory Formation Different in Those With Stress-Related Psychiatric Disorders 2Health News:Electronic Submission for Dental Predeterminations May Increase Efficiency, Patient Satisfaction 2
...of US army Gale Pollock was inspired to become a n...der brother after he was wounded in Vietnam. Thirt... Corps. // "I decided to join the army when I was...was injured in Vietnam and the army medical depart...
...tion was found at the St. Michael's and Toronto Ge...splant paired exchange occurred. The scenario was... dying //of kidney disease and the other unable to... because they weren't a compatible blood type. T...
...e University of Melbourne and La Trobe University ...t of fibre in grains such as wheat and barley. Wit... the Aussie researchers fell that this discovery w...content of foods. The genes are important in the ...
... to win and lose; money; of course but a new repor...r health. The reason is attributed to long hours a... state of casino working conditions by the GMB uni...repares to bid for a licence to operate a Las Vega...
Other Medicine News:Health News:Joining The Military 'My Best Move' - US Army Nursing Chief 2Health News:Innovative solution to help reduce the waiting times for kidney transplants 2Health News:Gamble for money, but casino workers gamble with their health! 2
(Date:12/1/2008)... , , CHICAGO, Dec. 2 /PRNewswire-USNewswi...mmography (PEM), a new technique for imaging the b... a woman,s hormonal status, two factors that limit... at detecting cancer. Results will be presented to...ety of North America (RSNA). , , "The abil...
(Date:12/1/2008)...ANAPOLIS, Dec. 1 Roche announced t...te differences in perceived pain and,discomfort a...HEK blood,glucose monitoring systems and lancing ...s indicated that, overall, the ACCU-CHEK Aviva and...systems and the ACCU-CHEK Multiclix, ACCU-CHEK,So...
(Date:12/1/2008)...OUTH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/ -...ounced that dosing of subjects has begun in study ...dose Phase 1b study of trodusquemine (MSI-1436) in...s a novel therapeutic for the treatment of type 2 ...ipherally to regulate insulin and leptin pathways ...
(Date:12/1/2008)...DIEGO, Dec. 1 Vical Inco...eipt of a $1.0 million milestone payment from Merc...ion of a Phase I clinical trial of an investigatio...te vaccine is based on Vical,s DNA gene delivery t...nscriptase (hTERT). hTERT is the subject of separa...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 2600 1Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 2600 2Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 2600 3Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain 2600 4Affordability Crisis in Managed Care Explored at Conference of Health Plan Executives 23552 1Affordability Crisis in Managed Care Explored at Conference of Health Plan Executives 23552 2Breastfeeding com Becomes a Premier Resource on Child Health 23551 1Breastfeeding com Becomes a Premier Resource on Child Health 23551 2Disaboom Survey Reveals 52 Percent of Americans Would Rather be Dead Than Disabled 23548 1Disaboom Survey Reveals 52 Percent of Americans Would Rather be Dead Than Disabled 23548 2Disaboom Survey Reveals 52 Percent of Americans Would Rather be Dead Than Disabled 23548 3Disaboom Survey Reveals 52 Percent of Americans Would Rather be Dead Than Disabled 23548 4
...bstantial Response Rate,in Two Clinical Trials , C...udy of Oral,Azacitidine , Exelixis Reports Compreh...ts Integrated Data From Phase II Clinical Trials,o... in Hematologic Malignancies and,Advanced Solid Tu...osing Schedules in,MDS and in Combination with Val...
...-,Phytopharm plc (LSE: PYM) ("Phytopharm" or the "...g that Cogane(tm) reverses the,changes in the area...s data will be presented by Dr Jonathan Brotchie, ...s disease at ,The,11th International Congress of P...in Istanbul, Turkey and published in The Movement,...
Other Medicine Technology:Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 2Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 3Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 4Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 5Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 6Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 7Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 8Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 9Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 10Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 11Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 12Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 13Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 14Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 15Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 16Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 17Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 18Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 19Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 20Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 21Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 22Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 23Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 24Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 25Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 26Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 27Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 28Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 29Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5